Wang Zhao, Zhang Fan, Xiong Jianhua, Mao Zhiqiang, Liu Zhihong
Hubei Collaborative Innovation Center for Advanced Organic Chemical Materials & Ministry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, College of Chemistry and Chemical Engineering, Hubei University, Wuhan 430062, China.
Hubei Collaborative Innovation Center for Advanced Organic Chemical Materials & Ministry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, College of Chemistry and Chemical Engineering, Hubei University, Wuhan 430062, China.
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Feb 5;246:118960. doi: 10.1016/j.saa.2020.118960. Epub 2020 Sep 18.
Drug-induced liver injury (DILI) is a prevalent liver disease and the leading cause for acute liver failure (ALF) worldwide. Screening of DILI in patients is central to ensure drug safety and improve therapy efficiency. Mounting evidences revealed that peroxynitrite (ONOO) is involved in the DILI process and can be a potential biomarker for DILI. Thus far, there are few two-photon fluorescence probes for ONOO that can accomplish this challenging task in DILI liver tissues. Hereby, a peroxynitrite activatable two-photon fluorescence probe BN-PN for the imaging of ONOO in mice liver was elaborately constructed. The probe specifically reacted with peroxynitrite to furnish 140-fold fluorescence increase in vitro, which elucidated a high sensitivity for ONOO. Thus, subtle changes of ONOO levels in live cells can be sensitively imaged with this probe by two-photon microscopy. The probe also denoted the overproduction of ONOO in APAP-induced liver injury, and proved that administration with NAC can effectively alleviate DILI and reduce ONOO production in mouse liver. Further, the probe demonstrated the rapid rise of ONOO level in the liver of DILI mice administrated with alcohol. This work disclosed the rational construction of a two-photon fluorescence probe-based DILI screening method, which would help the estimation of drug safety and new drug development.
药物性肝损伤(DILI)是一种常见的肝脏疾病,也是全球急性肝衰竭(ALF)的主要原因。对患者进行DILI筛查对于确保药物安全和提高治疗效率至关重要。越来越多的证据表明,过氧亚硝酸盐(ONOO)参与了DILI过程,并且可能是DILI的潜在生物标志物。到目前为止,很少有用于ONOO的双光子荧光探针能够在DILI肝组织中完成这项具有挑战性的任务。在此,精心构建了一种用于小鼠肝脏中ONOO成像的过氧亚硝酸盐可激活双光子荧光探针BN-PN。该探针与过氧亚硝酸盐特异性反应,在体外使荧光增强140倍,这表明对ONOO具有高灵敏度。因此,通过双光子显微镜用该探针可以灵敏地对活细胞中ONOO水平的细微变化进行成像。该探针还表明对乙酰氨基酚诱导的肝损伤中ONOO过量产生,并证明给予NAC可以有效减轻DILI并降低小鼠肝脏中ONOO的产生。此外,该探针显示给予酒精的DILI小鼠肝脏中ONOO水平迅速升高。这项工作揭示了基于双光子荧光探针的DILI筛查方法的合理构建,这将有助于评估药物安全性和新药开发。